scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1008759631 |
P356 | DOI | 10.1007/S10096-016-2652-6 |
P698 | PubMed publication ID | 27142585 |
P50 | author | Dorothée Valance | Q87383375 |
Jerome Allyn | Q64900383 | ||
P2093 | author name string | L Corradi | |
O Martinet | |||
N Allou | |||
P Augustin | |||
D Vandroux | |||
T Galas | |||
Y Charifou | |||
P2860 | cites work | Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012 | Q29615429 |
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies | Q29615686 | ||
Therapeutic drug monitoring of amikacin in septic patients. | Q33754166 | ||
Revisiting the loading dose of amikacin for patients with severe sepsis and septic shock | Q33919190 | ||
Incidence of and significant risk factors for aminoglycoside-associated nephrotoxicity in patients dosed by using individualized pharmacokinetic monitoring | Q34061646 | ||
Aminoglycoside dosing weight correction factors for patients of various body sizes | Q35111974 | ||
Dynamic changes of microbial flora and therapeutic consequences in persistent peritonitis | Q35162610 | ||
Prevalence and risk factors for aminoglycoside nephrotoxicity in intensive care units | Q37247721 | ||
Impact of 30 mg/kg amikacin and 8 mg/kg gentamicin on serum concentrations in critically ill patients with severe sepsis. | Q40474926 | ||
Assessment of the National French recommendations regarding the dosing regimen of 8mg/kg of gentamicin in patients hospitalised in intensive care units. | Q40692247 | ||
Standard dosing of amikacin and gentamicin in critically ill patients results in variable and subtherapeutic concentrations | Q41348554 | ||
Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration | Q44483617 | ||
EUCAST technical note on Amphotericin B. | Q47575248 | ||
Electronic bed weighing vs daily fluid balance changes after cardiac surgery | Q48921033 | ||
Once- versus twice-daily amikacin regimen: efficacy and safety in systemic gram-negative infections. Scandinavian Amikacin Once Daily Study Group. | Q50529699 | ||
Update on good use of injectable aminoglycosides, gentamycin, tobramycin, netilmycin, amikacin. Pharmacological properties, indications, dosage, and mode of administration, treatment monitoring | Q84537814 | ||
First-dose pharmacokinetics of aminoglycosides in critically ill haematological malignancy patients | Q86127368 | ||
P433 | issue | 7 | |
P921 | main subject | gentamicin | Q422482 |
sepsis | Q183134 | ||
P304 | page(s) | 1187-1193 | |
P577 | publication date | 2016-05-03 | |
P1433 | published in | European Journal of Clinical Microbiology & Infectious Diseases | Q15754378 |
P1476 | title | A study to evaluate the first dose of gentamicin needed to achieve a peak plasma concentration of 30 mg/l in patients hospitalized for severe sepsis | |
P478 | volume | 35 |
Q38432516 | Short-Course Adjunctive Gentamicin as Empirical Therapy in Patients With Severe Sepsis and Septic Shock: A Prospective Observational Cohort Study | cites work | P2860 |
Search more.